image: Cartoon describing the synthesis process of the Nanogel (backpack). This material relates to a paper that appeared in the Nov. 11, 2020, issue of Science Translational Medicine, published by AAAS. The paper, by S.K. Eskandari at Harvard Medical School in Boston, MA; and colleagues was titled, "Regulatory T cells engineered with TCR signaling-responsive IL-2 nanogels suppress alloimmunity in sites of antigen encounter." view more
Credit: [Credit: Eskandari <i>et al</i>.]